Reviscon

• High lubrication
• Better shock absorption on joint surfaces
• Reduction of mechanical stress on the joint
• Long lasting effectiveness

NETWORK STRUCTURE OF HYALURONIC ACID

VSY Biotechnology prevents the degradation of hyaluronic acid by creating a structured model of hyaluronic acid, so it does not need stabilizers (sorbitol, mannitol, etc.) that have a short half-life and act only at the beginning and are exogenous particles.

Many studies support that IA application of hyaluronic acid is a symptom-modifying approach that has been found to be safe and effective in reducing osteoarthritis pain and can significantly reduce the rate of joint structural deterioration.

Excellent rheological model

• To achieve higher shear viscosity
• Effective pain relief
• Long-term mobility
• It enhances the production of endogenous hyaluronic acid, modulating nociceptive activity, and reduces the activation and synthesis of pro-inflammatory cytokines.

The complex biochemical effects of hyaluronic acid in the synovium and extracellular matrix of articular cartilage include interactions between exogenously administered hyaluronic acid and articular cartilage, subchondral bone, matrix proteoglycans, and collagen.

Revsicon IA injections are a treatment for osteoarthritis of the II and III degrees of the Kellgren Lawrence scale